Analystreport

Atossa Genetics (NASDAQ: ATOS) was given a new $10.00 price target on by analysts at Noble Financial. They now have a "buy" rating on the stock.

Atossa Therapeutics, Inc.  (ATOS) 
Last atossa therapeutics, inc. earnings: 11/13 04:10 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.atossagenetics.com